XML 43 R25.htm IDEA: XBRL DOCUMENT
v3.22.4

Net Loss Per Share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Earnings Per Share [Abstract] |
Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss | The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the periods indicated due to their anti-dilutive effect:
|  | Year Ended December 31, |
|  | 2022 |  |  | 2021 |
Stock options to purchase common stock |  |  | 3,161,917 |  |  |  | 2,406,668 |
Unvested restricted stock units |  |  | 1,095,738 |  |  |  | 106,394 |
Warrants to purchase common stock 1 |  |  | 13,166,283 |  |  |  | 58,923 |
Total |  |  | 17,423,938 |  |  |  | 2,571,985 |
1 The table above excludes pre-funded warrants issued in connection with the July 2022 public offering (see Note 7).

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration